Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHP Exiting Oral Generics Business; K-Dur Settlement With FTC Near

Executive Summary

American Home Products is phasing out its oral solid dosage form generic drug business, the company said in documents filed as part of the Federal Trade Commission suit against ESI Lederle

You may also be interested in...



Baxter Adding $200 Mil. In Critical Care Rx Sales Via ESI Lederle Deal

Baxter is adding about $200 mil. in annual sales to its anesthesia/critical care line via the acquisition of ESI Lederle from Wyeth

Baxter Adding $200 Mil. In Critical Care Rx Sales Via ESI Lederle Deal

Baxter is adding about $200 mil. in annual sales to its anesthesia/critical care line via the acquisition of ESI Lederle from Wyeth

Baxter Heparin Production Increasing Following Wyeth Recall

Baxter is increasing production of heparin sodium following a shortage of the anticoagulant

Related Content

UsernamePublicRestriction

Register

PS038845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel